Dr. Kiu Adejoro
Senior Research Fellow
Dr. Kiu Adejoro is a Senior Research Fellow at the Institute of Cancer Policy, specialising in the economics of cancer medicines and health technology assessment processes. Her research focuses on the structural drivers of drug access inequity — from HTA methodology to pricing negotiations and managed entry agreements.
Before joining the Institute, Kiu worked as an economist at NICE and spent three years as a consultant to the WHO on pharmaceutical pricing policy. She holds a DPhil in Health Economics from the University of Oxford and an MSc in Global Health Policy from the London School of Hygiene and Tropical Medicine.
Kiu leads the Institute’s EU Drug Pricing Reform programme, which has directly informed deliberations in the European Parliament on the implementation of the Joint Clinical Assessment Regulation.
Selected publications
- Adejoro K, Sullivan R, Henriksen M (2026). The cost burden of cancer medicines in European health systems. Lancet Oncology.
- Adejoro K et al. (2025). A framework for cancer drug pricing reform in the European Union. ICP Policy Brief.
- Adejoro K (2024). Confidential managed entry agreements and their impact on access equity. Health Policy.